- A new White Coat Waste (WCW) investigation exposes Marshall BioResources (aka Marshall Farms) — the nation’s largest commercial breeder of dogs and cats for labs — as a key supplier for cruel taxpayer-funded experiments. - Marshall confines more than 15,000 dogs and 1,100 cats at its breeding facilities in upstate New York, according to its most recent federal inspections. - Freedom of Information Act (FOIA) records and other documents uncovered by WCW tie dogs and cats from Marshall to ongoing National Institutes of Health (NIH)-funded experiments that involve inducing heart failure, obesity, diabetes, spinal cord injuries, decerebration, toxoplasmosis infection, and other painful, ultimately deadly, procedures. - Marshall has supplied beagles for some of the most disturbing experiments ever exposed by WCW, including Fauci-funded tests that cut the dogs’ vocal cords, infested them with ticks and flies, and force-fed them experimental drugs. - Just since Secretary Robert F. Kennedy, Jr. took office in February 2025, the NIH has spent over $175 million in new funding on cat and dog experimentation, including renewing support for many of Fauci’s dog and cat labs that abuse animals from Marshall. - WCW is working with Congress to cut taxpayer funding to Marshall Farms and all other dog and cat labs and their shady suppliers.

The biosecurity landscape is rapidly evolving. To stay ahead of future outbreaks, we’re partnering with @IsomorphicLabs to outline our approach to bioresilience. Here’s how we’re deploying frontier AI to build proactive defenses for global health →

Another timelapse view into our beloved @Space_Station Lifesciences Glovebox – this time to harvest the stem cells and conclude the experiment (May 28 post). This goal of this experiment was to produce stem cells in large numbers, using the innovative microgravity bioreactor seen inside the glovebox. Stem cell therapies provide significant benefits to help patients fight disease or recover from chemotherapy. The scientists behind this experiment hypothesized that space-grown cells may retain the ability to continuously divide for longer than stem cells on Earth, which could create larger supplies of cells crucial to provide therapies for patients back on Earth. Stay tuned, because the initial results appear incredibly promising!

The FDA has approved a revolutionary light-activated polymer system that repairs severed nerves without the need for traditional surgical stitches. The US Food and Drug Administration has officially cleared a revolutionary nerve-repair system that replaces traditional surgical stitches with light-activated polymers. Developed by medical technology firm Tissium based on research from MIT, this innovation utilizes a biocompatible polymer to create a flexible, 3D-printed cuff around severed nerves. Instead of the painstaking process of manual suturing under a microscope, surgeons can now apply a liquid prepolymer that cures instantly with light, creating a secure seal that allows delicate nerve tissues to knit back together naturally. This milestone marks the first FDA approval for Tissium, culminating over a decade of research into poly(glycerol sebacate acrylate) materials. The implant is designed to be fully bioresorbable, meaning it safely disappears once the nerve has healed, reducing the risk of inflammation or complications from permanent foreign materials. Beyond nerve reconstruction, the company is already scaling its manufacturing capabilities to adapt this technology for cardiovascular sealing and gastrointestinal hernia repairs, aiming to transform complex microsurgeries into streamlined, highly effective clinical solutions. source: Howes, L. (2025). FDA approves light-activated polymer for nerve repair without stitches. Chemical & Engineering News.

Walls that breathe. Bricks that grow. Cities that finally stop choking. A team of Dutch engineers just pulled off something straight out of science fiction. They built bricks that grow moss. Real, living moss. Spreading across walls like nature is reclaiming the city one square meter at a time. Behind the magic is a Leiden-based startup called Respyre. Their secret? A "bioreceptive" concrete made from 70% recycled material, rough and porous on purpose, designed so moss can cling, thrive, and multiply. Spray on a moss-growing gel. Wait around 12 weeks. Watch a dead concrete wall turn into a living green skin. And the moss isn't just for show. It eats CO₂. It traps nitrogen dioxide. It catches particulate matter floating in city air. It cools entire wall surfaces by 5–7°C during peak summer heat. It buffers noise. It builds tiny habitats for insects and urban wildlife. One square meter of moss can absorb up to 1.2 kg of CO₂ every single year. No roots clawing into the bricks. No structural damage. No irrigation systems. No fertilizer. No fancy maintenance routine. Just rainwater, humidity, and time. From a single square meter of starter moss, Respyre can grow up to 80 square meters of green wall coverage. Pilot projects are already running across the Netherlands. Schools. Apartment blocks in Amsterdam's Rivierenbuurt. Even the bases of wind turbines in collaboration with Dutch energy company Eneco. Imagine a future where every grey building exhales oxygen. Where the walls themselves cool the streets below. Where the city becomes the forest. It's not coming. It's already here. Brick by living brick. Source: Respyre (Leiden, Netherlands) / Positive News / IO+

Boredom is often a sign you are doing the job correctly. Markets spend long stretches without high-quality opportunities, so a calm, uneventful session is frequently healthier than a busy one. The urge to “make something happen” leads to forced trades, lower standards, and a slow leak of capital. Professionals treat inactivity as part of the process rather than a problem to be solved with more clicks. In practice, learning to tolerate boredom without manufacturing action is one of the rarest and most valuable skills a trader can develop.